Is frequent CD4+ T-lymphocyte count monitoring necessary for persons with counts >=300 cells/μL and HIV-1 suppression?
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 23315315.
- Also identified by DOI 10.1093/cid/cit004 and PMC identifier 3693489.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Among patients infected with human immunodeficiency virus (HIV), those with HIV-1 RNA <200 copies/mL and CD4 counts ≥300 cells/µL had a 97.1% probability of maintaining durable CD4 ≥200 cells/µL for 4 years. When non-HIV causes of CD4 lymphopenia were excluded, the probability rose to 99.2%. Our data support less frequent CD4 monitoring during viral suppression.
Medical subject headings
- Antiretroviral Therapy, Highly Active
- Drug Monitoring
- HIV Infections
- HIV-1
- Viral Load